Oshlack; Benjamin
Patent Applications and Registrations
Patent applications and USPTO patent grants for Oshlack; Benjamin.The latest application filed is for "pharmaceutical formulation containing gelling agent".
Company Profile
14.165.200
- Oshlack; Benjamin - Boca Raton FL
- Oshlack; Benjamin - New York NY
- Oshlack; Benjamin - Boca Rafon FL US
Patent Activity
| Patent | Date |
|---|---|
| Pharmaceutical formulation containing gelling agent Grant 11,135,171 - Wright , et al. October 5, 2 | 2021-10-05 |
| Oxycodone formulations Grant 10,660,886 - Oshlack , et al. | 2020-05-26 |
| Pharmaceutical Formulation Containing Gelling Agent App 20200138720 - Wright; Curtis ; et al. | 2020-05-07 |
| Tamper resistant oral opioid agonist formulations Grant 10,588,865 - Oshlack , et al. | 2020-03-17 |
| Pharmaceutical formulation containing gelling agent Grant 10,537,526 - Wright , et al. Ja | 2020-01-21 |
| Pharmaceutical formulation containing gelling agent Grant 10,500,160 - Wright , et al. Dec | 2019-12-10 |
| Tamper Resistant Oral Opioid Agonist Formulations App 20190350868 - Oshlack; Benjamin ; et al. | 2019-11-21 |
| Tamper resistant oral opioid agonist formulations Grant 10,350,173 - Oshlack , et al. July 16, 2 | 2019-07-16 |
| Pharmaceutical Formulation Containing Gelling Agent App 20190117580 - Wright; Curtis ; et al. | 2019-04-25 |
| Pharmaceutical Formulation Containing Gelling Agent App 20190110996 - Wright; Curtis ; et al. | 2019-04-18 |
| Pharmaceutical Formulation Containing Gelling Agent App 20190070119 - Wright; Curtis ; et al. | 2019-03-07 |
| Pharmaceutical formulation containing gelling agent Grant 10,206,881 - Wright , et al. Feb | 2019-02-19 |
| Controlled Release Hydrocodone Formulations App 20190022086 - Oshlack; Benjamin ; et al. | 2019-01-24 |
| Pharmaceutical Formulation Containing Gelling Agent App 20190015341 - Wright; Curtis ; et al. | 2019-01-17 |
| Controlled release hydrocodone formulations Grant 10,179,130 - Oshlack , et al. Ja | 2019-01-15 |
| Controlled Release Hydrocodone Formulations App 20180353502 - Oshlack; Benjamin ; et al. | 2018-12-13 |
| Pharmaceutical formulation containing gelling agent Grant 10,130,586 - Wright , et al. November 20, 2 | 2018-11-20 |
| Pharmaceutical products Grant 10,092,519 - Oshlack , et al. October 9, 2 | 2018-10-09 |
| Methods of manufacturing oral dosage forms Grant 10,076,516 - Oshlack , et al. September 18, 2 | 2018-09-18 |
| Pharmaceutical formulation containing gelling agent Grant 10,076,497 - Wright , et al. September 18, 2 | 2018-09-18 |
| Pharmaceutical formulation containing gelling agent Grant 10,071,057 - Wright , et al. September 11, 2 | 2018-09-11 |
| Pharmaceutical formulation containing gelling agent Grant 10,064,825 - Wright , et al. September 4, 2 | 2018-09-04 |
| Pharmaceutical formulation containing gelling agent Grant 10,064,824 - Wright , et al. September 4, 2 | 2018-09-04 |
| Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same Grant 10,039,720 - Oshlack , et al. August 7, 2 | 2018-08-07 |
| Methods of manufacturing oral formulations Grant 10,022,368 - Oshlack , et al. July 17, 2 | 2018-07-17 |
| Pharmaceutical Formulation Containing Gelling Agent App 20180147151 - Wright; Curtis ; et al. | 2018-05-31 |
| Pharmaceutical formulation containing gelling agent Grant 9,968,559 - Wright , et al. May 15, 2 | 2018-05-15 |
| Pharmaceutical Formulation Containing Gelling Agent App 20180125788 - Wright; Curtis ; et al. | 2018-05-10 |
| Opioid agonist formulations with releasable and sequestered antagonist Grant 9,949,930 - Breder , et al. April 24, 2 | 2018-04-24 |
| Pharmaceutical Formulation Containing Gelling Agent App 20180055771 - Wright; Curtis ; et al. | 2018-03-01 |
| Tamper Resistant Oral Opioid Agonist Formulations App 20180042859 - Oshlack; Benjamin ; et al. | 2018-02-15 |
| Pharmaceutical formulation containing gelling agent Grant 9,877,924 - Wright , et al. January 30, 2 | 2018-01-30 |
| Pharmaceutical Formulation Containing Gelling Agent App 20180021262 - Wright; Curtis ; et al. | 2018-01-25 |
| Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist And Gelling Agent App 20180021330 - Oshlack; Benjamin ; et al. | 2018-01-25 |
| Pharmaceutical formulation containing gelling agent Grant 9,872,836 - Wright , et al. January 23, 2 | 2018-01-23 |
| Pharmaceutical formulation containing gelling agent Grant 9,867,784 - Wright , et al. January 16, 2 | 2018-01-16 |
| Pharmaceutical formulation containing gelling agent Grant 9,867,783 - Wright , et al. January 16, 2 | 2018-01-16 |
| Pharmaceutical formulation containing gelling agent Grant 9,861,583 - Wright , et al. January 9, 2 | 2018-01-09 |
| Pharmaceutical formulation containing gelling agent Grant 9,861,582 - Wright , et al. January 9, 2 | 2018-01-09 |
| Oxycodone Formulations App 20170340626 - OSHLACK; Benjamin ; et al. | 2017-11-30 |
| Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent Grant 9,808,453 - Oshlack , et al. November 7, 2 | 2017-11-07 |
| Tamper resistant oral opioid agonist formulations Grant 9,801,828 - Oshlack , et al. October 31, 2 | 2017-10-31 |
| Pharmaceutical Formulation Containing Gelling Agent App 20170296533 - Wright; Curtis ; et al. | 2017-10-19 |
| Pharmaceutical formulation containing gelling agent Grant 9,757,341 - Wright , et al. September 12, 2 | 2017-09-12 |
| Oxycodone formulations Grant 9,750,736 - Oshlack , et al. September 5, 2 | 2017-09-05 |
| Pharmaceutical formulation containing gelling agent Grant 9,693,961 - Wright , et al. July 4, 2 | 2017-07-04 |
| Methods of providing analgesia Grant 9,682,077 - Oshlack , et al. June 20, 2 | 2017-06-20 |
| Methods of providing analgesia Grant 9,675,611 - Oshlack , et al. June 13, 2 | 2017-06-13 |
| Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist And Gelling Agent App 20170157115 - Oshlack; Benjamin ; et al. | 2017-06-08 |
| Controlled release hydrocodone formulations Grant 9,669,023 - Oshlack , et al. June 6, 2 | 2017-06-06 |
| Controlled release hydrocodone formulations Grant 9,669,022 - Oshlack , et al. June 6, 2 | 2017-06-06 |
| Controlled release hydrocodone formulations Grant 9,669,024 - Oshlack , et al. June 6, 2 | 2017-06-06 |
| Methods Of Manufacturing Oral Formulations App 20170151229 - Oshlack; Benjamin ; et al. | 2017-06-01 |
| Methods Of Providing Analgesia App 20170143697 - Oshlack; Benjamin ; et al. | 2017-05-25 |
| Once-A day oxycodone formulations Grant 9,655,894 - Oshlack , et al. May 23, 2 | 2017-05-23 |
| Once-a-day oxycodone formulations Grant 9,655,893 - Oshlack , et al. May 23, 2 | 2017-05-23 |
| Methods Of Manufacturing Oral Dosage Forms App 20170136006 - Oshlack; Benjamin ; et al. | 2017-05-18 |
| Tamper Resistant Dosage Form Comprising Co-extruded, Adverse Agent Particles And Process Of Making Same App 20170135959 - Oshlack; Benjamin ; et al. | 2017-05-18 |
| Tamper Resistant Oral Opioid Agonist Formulations App 20170119685 - Oshlack; Benjamin ; et al. | 2017-05-04 |
| Pharmaceutical Formulation Containing Gelling Agent App 20170112765 - Wright; Curtis ; et al. | 2017-04-27 |
| Naltrexone hydrochloride compositions App 20170100337 - Oshlack; Benjamin ; et al. | 2017-04-13 |
| Controlled Release Hydrocodone Formulations App 20170087153 - Oshlack; Benjamin ; et al. | 2017-03-30 |
| Controlled Release Hydrocodone Formulations App 20170087151 - Oshlack; Benjamin ; et al. | 2017-03-30 |
| Methods Of Providing Analgesia App 20170087152 - Oshlack; Benjamin ; et al. | 2017-03-30 |
| Pharmaceutical Formulation Containing Gelling Agent App 20170065524 - Wright; Curtis ; et al. | 2017-03-09 |
| Pharmaceutical Formulation Containing Gelling Agent App 20170065525 - Wright; Curtis ; et al. | 2017-03-09 |
| Tamper resistant dosage form comprising co-extruded, sequestered adverse agent particles and process of making same Grant 9,579,286 - Oshlack , et al. February 28, 2 | 2017-02-28 |
| Controlled release hydrocodone formulations Grant 9,572,805 - Oshlack , et al. February 21, 2 | 2017-02-21 |
| Controlled release hydrocodone formulations Grant 9,572,804 - Oshlack , et al. February 21, 2 | 2017-02-21 |
| Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent Grant 9,561,225 - Oshlack , et al. February 7, 2 | 2017-02-07 |
| Pharmaceutical Formulation Containing Gelling Agent App 20170020864 - Wright; Curtis ; et al. | 2017-01-26 |
| Pharmaceutical Formulation Containing Gelling Agent App 20170020863 - Wright; Curtis ; et al. | 2017-01-26 |
| Controlled release hydrocodone formulations Grant 9,526,724 - Oshlack , et al. December 27, 2 | 2016-12-27 |
| Pharmaceutical formulation containing gelling agent Grant 9,517,207 - Wright , et al. December 13, 2 | 2016-12-13 |
| Controlled release hydrocodone formulations Grant 9,517,236 - Oshlack , et al. December 13, 2 | 2016-12-13 |
| Controlled release hydrocodone formulations Grant 9,504,681 - Oshlack , et al. November 29, 2 | 2016-11-29 |
| Pharmaceutical Compositions App 20160317456 - Oshlack; Benjamin ; et al. | 2016-11-03 |
| Tamper-resistant oral opioid agonist formulations Grant 9,456,989 - Oshlack , et al. October 4, 2 | 2016-10-04 |
| Controlled Release Hydrocodone Formulations App 20160228429 - Oshlack; Benjamin ; et al. | 2016-08-11 |
| Pharmaceutical formulation containing gelling agent Grant 9,387,173 - Wright , et al. July 12, 2 | 2016-07-12 |
| Pharmaceutical formulation containing gelling agent Grant 9,387,174 - Wright , et al. July 12, 2 | 2016-07-12 |
| Controlled Release Hydrocodone Formulations App 20160158224 - Oshlack; Benjamin ; et al. | 2016-06-09 |
| Controlled Release Hydrocodone Formulations App 20160158223 - Oshlack; Benjamin ; et al. | 2016-06-09 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151291 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151360 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151297 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151357 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151355 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151358 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151290 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151356 - Wright; Curtis ; et al. | 2016-06-02 |
| Controlled Release Hydrocodone Formulations App 20160151292 - Oshlack; Benjamin ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151277 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151289 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151499 - Wright; Curtis ; et al. | 2016-06-02 |
| Controlled Release Hydrocodone Formulations App 20160151361 - Oshlack; Benjamin ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151502 - Wright; Curtis ; et al. | 2016-06-02 |
| Controlled Release Hydrocodone Formulations App 20160151288 - Oshlack; Benjamin ; et al. | 2016-06-02 |
| Controlled release hydrocodone formulations Grant 9,320,717 - Oshlack , et al. April 26, 2 | 2016-04-26 |
| Pharmaceutical formulation containing gelling agent Grant 9,308,171 - Wright , et al. April 12, 2 | 2016-04-12 |
| Pharmaceutical formulation containing gelling agent Grant 9,308,170 - Wright , et al. April 12, 2 | 2016-04-12 |
| Controlled release hydrocodone formulations Grant 9,289,391 - Oshlack , et al. March 22, 2 | 2016-03-22 |
| Tamper-resistant oral opioid agonist formulations Grant 9,278,073 - Oshlack , et al. March 8, 2 | 2016-03-08 |
| Controlled release hydrocodone formulations Grant 9,278,074 - Oshlack , et al. March 8, 2 | 2016-03-08 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160058716 - Wright; Curtis ; et al. | 2016-03-03 |
| Once-a-day Oxycodone Formulations App 20160030419 - OSHLACK; Benjamin ; et al. | 2016-02-04 |
| Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist And Gelling Agent App 20160008350 - Oshlack; Benjamin ; et al. | 2016-01-14 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160000712 - Wright; Curtis ; et al. | 2016-01-07 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160000718 - Wright; Curtis ; et al. | 2016-01-07 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160000719 - Wright; Curtis ; et al. | 2016-01-07 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160000717 - Wright; Curtis ; et al. | 2016-01-07 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160000776 - Wright; Curtis ; et al. | 2016-01-07 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160000723 - Wright; Curtis ; et al. | 2016-01-07 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150374631 - Wright; Curtis ; et al. | 2015-12-31 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150374628 - Wright; Curtis ; et al. | 2015-12-31 |
| Pharmaceutical Products App 20150366811 - OSHLACK; Benjamin ; et al. | 2015-12-24 |
| Controlled release hydrocodone formulations Grant 9,205,056 - Oshlack , et al. December 8, 2 | 2015-12-08 |
| Controlled release hydrocodone formulations Grant 9,205,055 - Oshlack , et al. December 8, 2 | 2015-12-08 |
| Controlled release hydrocodone formulations Grant 9,198,863 - Oshlack , et al. December 1, 2 | 2015-12-01 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150283130 - Wright; Curtis ; et al. | 2015-10-08 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150283128 - Wright; Curtis ; et al. | 2015-10-08 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150283129 - Wright; Curtis ; et al. | 2015-10-08 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150283250 - Wright; Curtis ; et al. | 2015-10-08 |
| Pharmaceutical product comprising a sequestered agent Grant 9,149,436 - Oshlack , et al. October 6, 2 | 2015-10-06 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150273064 - Wright; Curtis ; et al. | 2015-10-01 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150273065 - Wright; Curtis ; et al. | 2015-10-01 |
| Controlled Release Hydrocodone Formulations App 20150265537 - Oshlack; Benjamin ; et al. | 2015-09-24 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150265606 - Wright; Curtis ; et al. | 2015-09-24 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150265603 - Wright; Curtis ; et al. | 2015-09-24 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150265607 - Wright; Curtis ; et al. | 2015-09-24 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150265602 - Wright; Curtis ; et al. | 2015-09-24 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150265604 - Wright; Curtis ; et al. | 2015-09-24 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150265605 - Wright; Curtis ; et al. | 2015-09-24 |
| Controlled Release Hydrocodone Formulations App 20150258090 - Oshlack; Benjamin ; et al. | 2015-09-17 |
| Controlled Release Hydrocodone Formulations App 20150258089 - Oshlack; Benjamin ; et al. | 2015-09-17 |
| Controlled Release Hydrocodone Formulations App 20150238418 - Oshlack; Benjamin ; et al. | 2015-08-27 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150238481 - Wright; Curtis ; et al. | 2015-08-27 |
| Tamper-resistant Oral Opioid Agonist Formulations App 20150231086 - Oshlack; Benjamin ; et al. | 2015-08-20 |
| Once-a-day Oxycodone Formulations App 20150231131 - OSHLACK; Benjamin ; et al. | 2015-08-20 |
| Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent Grant 9,101,668 - Oshlack , et al. August 11, 2 | 2015-08-11 |
| Controlled Release Hydrocodone Formulations App 20150216809 - Oshlack; Benjamin ; et al. | 2015-08-06 |
| Controlled Release Hydrocodone Formulations App 20150216810 - Oshlack; Benjamin ; et al. | 2015-08-06 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150182628 - Wright; Curtis ; et al. | 2015-07-02 |
| Tamper-resistant Oral Opioid Agonist Formulations App 20150182467 - Oshlack; Benjamin ; et al. | 2015-07-02 |
| Disposal System For Transdermal Dosage Form App 20150182474 - Marcenyac; Geraldine ; et al. | 2015-07-02 |
| Controlled Release Hydrocodone Formulations App 20150174121 - Oshlack; Benjamin ; et al. | 2015-06-25 |
| Controlled release hydrocodone Grant 9,060,940 - Oshlack , et al. June 23, 2 | 2015-06-23 |
| Pharmaceutical formulation containing gelling agent Grant 9,060,976 - Wright , et al. June 23, 2 | 2015-06-23 |
| Controlled release hydrocodone formulations Grant 9,056,052 - Oshlack , et al. June 16, 2 | 2015-06-16 |
| Controlled release hydrocodone formulations Grant 9,056,107 - Oshlack , et al. June 16, 2 | 2015-06-16 |
| Pharmaceutical formulation containing gelling agent Grant 9,044,435 - Wright , et al. June 2, 2 | 2015-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150147391 - Wright; Curtis ; et al. | 2015-05-28 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150148319 - Wright; Curtis ; et al. | 2015-05-28 |
| Controlled Release Hydrocodone Formulations App 20150148367 - Oshlack; Benjamin ; et al. | 2015-05-28 |
| Pharmaceutical formulation containing gelling agent Grant 9,040,084 - Wright , et al. May 26, 2 | 2015-05-26 |
| Once-a-day Oxycodone Formulations App 20150140095 - OSHLACK; Benjamin ; et al. | 2015-05-21 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150140083 - Wright; Curtis ; et al. | 2015-05-21 |
| Pharmaceutical formulation containing gelling agent Grant 9,034,376 - Wright , et al. May 19, 2 | 2015-05-19 |
| Controlled release hydrocodone formulations Grant 9,023,401 - Oshlack , et al. May 5, 2 | 2015-05-05 |
| Opioid Agonist Formulations With Releasable And Sequestered Antagonist App 20150110879 - Breder; Christopher ; et al. | 2015-04-23 |
| Controlled Release Hydrocodone Formulations App 20150110870 - Oshlack; Benjamin ; et al. | 2015-04-23 |
| Pharmaceutical formulation containing gelling agent Grant 8,999,961 - Wright , et al. April 7, 2 | 2015-04-07 |
| Pharmaceutical Combinations Of Hydrocodone And Naltrexone App 20150080423 - OSHLACK; Benjamin ; et al. | 2015-03-19 |
| Controlled release hydrocodone formulations Grant 8,980,291 - Oshlack , et al. March 17, 2 | 2015-03-17 |
| Controlled release hydrocodone formulations Grant 8,975,273 - Oshlack , et al. March 10, 2 | 2015-03-10 |
| Controlled release hydrocodone formulations Grant 8,951,555 - Oshlack , et al. February 10, 2 | 2015-02-10 |
| Controlled Release Hydrocodone Formulations App 20150037409 - Oshlack; Benjamin ; et al. | 2015-02-05 |
| Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist and Gelling Agent App 20150031718 - Wright; Curtis ; et al. | 2015-01-29 |
| Tamper-resistant oral opioid agonist formulations Grant 8,936,812 - Oshlack , et al. January 20, 2 | 2015-01-20 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150005331 - Wright; Curtis ; et al. | 2015-01-01 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150005333 - Wright; Curtis ; et al. | 2015-01-01 |
| Controlled Release Hydrocodone Formulations App 20140377348 - Oshlack; Benjamin ; et al. | 2014-12-25 |
| Pharmaceutical Formulation Containing Gelling Agent App 20140371257 - Wright; Curtis ; et al. | 2014-12-18 |
| Pharmaceutical Formulation Containing Gelling Agent App 20140357657 - Wright; Curtis ; et al. | 2014-12-04 |
| Pharmaceutical formulation containing gelling agent Grant 8,871,265 - Wright , et al. October 28, 2 | 2014-10-28 |
| Sequestered Antagonist Formulations App 20140296276 - Breder; Christopher ; et al. | 2014-10-02 |
| Controlled Release Hydrocodone Formulations App 20140271840 - Oshlack; Benjamin ; et al. | 2014-09-18 |
| Opiod agonist formulations with releasable and sequestered antagonist Grant 8,815,287 - Breder , et al. August 26, 2 | 2014-08-26 |
| Pharmaceutical Formulation Containing Gelling Agent App 20140228390 - Wright; Curtis ; et al. | 2014-08-14 |
| Pharmaceutical Formulation Containing Gelling Agent App 20140213606 - Wright; Curtis ; et al. | 2014-07-31 |
| Abuse Resistant Opioid Containing Transdermal Systems App 20140199383 - Tavares; Lino ; et al. | 2014-07-17 |
| Controlled Release Hydrocodone App 20140199394 - Oshlack; Benjamin ; et al. | 2014-07-17 |
| Sequestered antagonist formulations Grant 8,758,825 - Breder , et al. June 24, 2 | 2014-06-24 |
| Controlled release hydrocodone Grant 8,715,721 - Oshlack , et al. May 6, 2 | 2014-05-06 |
| Controlled Release Hydrocodone Formulations App 20140112981 - Oshlack; Benjamin ; et al. | 2014-04-24 |
| Sequestered Antagonist Formulations App 20140099376 - Breder; Christopher ; et al. | 2014-04-10 |
| Tamper-resistant Oral Opioid Agonist Formulations App 20140099369 - Oshlack; Benjamin ; et al. | 2014-04-10 |
| Controlled release hydrocodone formulations Grant 8,647,667 - Oshlack , et al. February 11, 2 | 2014-02-11 |
| Pharmaceutical formulation containing gelling agent Grant 8,609,683 - Wright , et al. December 17, 2 | 2013-12-17 |
| Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist And Gelling Agent App 20130317051 - Oshlack; Benjamin ; et al. | 2013-11-28 |
| Opiod Agonist Formulations with Releasable And Sequestered Antagonist App 20130309303 - Breder; Christopher ; et al. | 2013-11-21 |
| Tamper-resistant oral opioid agonist formulations Grant 8,586,088 - Oshlack , et al. November 19, 2 | 2013-11-19 |
| Controlled Release Hydrocodone Formulations App 20130302418 - Oshlack; Benjamin ; et al. | 2013-11-14 |
| Pharmaceutical Formulation Containing Gelling Agent App 20130303494 - Wright; Curtis ; et al. | 2013-11-14 |
| Controlled Release Hydrocodone App 20130295177 - Oshlack; Benjamin ; et al. | 2013-11-07 |
| Controlled release hydrocodone Grant 8,551,520 - Oshlack , et al. October 8, 2 | 2013-10-08 |
| Pharmaceutical Formulation Containing Gelling Agent App 20130261143 - Wright; Curtis ; et al. | 2013-10-03 |
| Pharmaceutical Formulation Containing Gelling Agent App 20130261145 - Wright; Curtis ; et al. | 2013-10-03 |
| Pharmaceutical Formulation Containing Gelling Agent App 20130261144 - Wright; Curtis ; et al. | 2013-10-03 |
| Tamper-resistant Oral Opioid Agonist Formulations App 20130251789 - OSHLACK; Benjamin ; et al. | 2013-09-26 |
| Sequestered Antagonist Formulations App 20130251812 - Breder; Christopher ; et al. | 2013-09-26 |
| Pharmaceutical Formulation Containing Gelling Agent App 20130245055 - Wright; Curtis ; et al. | 2013-09-19 |
| Pharmaceutical formulation containing gelling agent Grant 8,529,948 - Wright , et al. September 10, 2 | 2013-09-10 |
| Pharmaceutical formulations containing opioid agonist, opioid antagonist and gelling agent Grant 8,524,275 - Oshlack , et al. September 3, 2 | 2013-09-03 |
| Opioid agonist formulations with releasable and sequestered antagonist Grant 8,518,443 - Breder , et al. August 27, 2 | 2013-08-27 |
| Pharmaceutical Formulation Containing Gelling Agent App 20130217716 - Wright; Curtis ; et al. | 2013-08-22 |
| Controlled Release Hydrocodone App 20130158061 - Oshlack; Benjamin ; et al. | 2013-06-20 |
| Sequestered antagonist formulations Grant 8,465,774 - Breder , et al. June 18, 2 | 2013-06-18 |
| Pharmaceutical composition containing gelling agent Grant 8,389,007 - Wright , et al. March 5, 2 | 2013-03-05 |
| Controlled release hydrocodone formulations Grant 8,361,499 - Oshlack , et al. January 29, 2 | 2013-01-29 |
| Tamper-resistant oral opioid agonist formulations Grant 8,357,399 - Oshlack , et al. January 22, 2 | 2013-01-22 |
| Controlled Release Oxycodone Compositions App 20130011543 - Oshlack; Benjamin ; et al. | 2013-01-10 |
| Controlled Release Oxycodone Compositions App 20130012533 - Oshlack; Benjamin ; et al. | 2013-01-10 |
| Pharmaceutical formulation containing gelling agent Grant 8,337,888 - Wright , et al. December 25, 2 | 2012-12-25 |
| Tamper-resistant Oral Opioid Agonist Formulations App 20120288565 - Oshlack; Benjamin ; et al. | 2012-11-15 |
| Opioid Agonist Formulations with Releasable And Sequestered Antagonist App 20120288567 - Breder; Christopher ; et al. | 2012-11-15 |
| Controlled Release Hydrocodone Formulations App 20120263788 - OSHLACK; Benjamin ; et al. | 2012-10-18 |
| Tamper-resistant oral opioid agonist formulations Grant 8,236,351 - Oshlack , et al. August 7, 2 | 2012-08-07 |
| Controlled release hydrocodone formulations Grant 8,231,898 - Oshlack , et al. July 31, 2 | 2012-07-31 |
| Opioid agonist formulations with releasable and sequestered antagonist Grant 8,231,901 - Breder , et al. July 31, 2 | 2012-07-31 |
| Pharmaceutical Formulation Containing Gelling Agent App 20120108622 - Wright; Curtis ; et al. | 2012-05-03 |
| Controlled release hydrocodone formulations Grant 8,142,811 - Oshlack , et al. March 27, 2 | 2012-03-27 |
| Controlled Release Hydrocodone Formulations App 20110262532 - Oshlack; Benjamin ; et al. | 2011-10-27 |
| Opioid Agonist Formulations With Releasable And Sequestered Antagonist App 20110256226 - Breder; Christopher ; et al. | 2011-10-20 |
| Pharmaceutical Formulations Containing Opioid Agonist, Opioid Antagonist And Gelling Agent App 20110230510 - Oshlack; Benjamin ; et al. | 2011-09-22 |
| Controlled release hydrocodone formulations Grant 7,943,174 - Oshlack , et al. May 17, 2 | 2011-05-17 |
| Pharmaceutical combinations of oxycodone and naloxone Grant 7,943,173 - Breder , et al. May 17, 2 | 2011-05-17 |
| Once-a-day Oxycodone Formulations App 20110104214 - Oshlack; Benjamin ; et al. | 2011-05-05 |
| Tamper-resistant Oral Opioid Agonist Formulations App 20110097404 - Oshlack; Benjamin ; et al. | 2011-04-28 |
| Opioid agonist formulations with releasable and sequestered antagonist Grant 7,914,818 - Breder , et al. March 29, 2 | 2011-03-29 |
| Controlled Release Hydrocodone Formulations App 20110038927 - Oshlack; Benjamin ; et al. | 2011-02-17 |
| Once-a-day oxycodone formulations Grant 7,846,476 - Oshlack , et al. December 7, 2 | 2010-12-07 |
| Tamper-resistant oral opioid agonist formulations Grant 7,842,309 - Oshlack , et al. November 30, 2 | 2010-11-30 |
| Tamper-resistant oral opioid agonist formulations Grant 7,842,311 - Oshlack , et al. November 30, 2 | 2010-11-30 |
| Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent Grant 7,842,307 - Oshlack , et al. November 30, 2 | 2010-11-30 |
| Sustained-release gel coated compositions Grant 7,790,215 - Sackler , et al. September 7, 2 | 2010-09-07 |
| Melt-extruded Orally Administrable Opioid Formulations App 20100172974 - Oshlack; Benjamin ; et al. | 2010-07-08 |
| Pharmaceutical formulation containing gelling agent App 20100168148 - Wright; Curtis ; et al. | 2010-07-01 |
| Tamper-resistant oral opioid agonist formulations Grant 7,718,192 - Oshlack , et al. May 18, 2 | 2010-05-18 |
| Controlled Release Oxycodone Compositions App 20100092570 - Oshlack; Benjamin ; et al. | 2010-04-15 |
| Tamper-resistant oral opioid agonist formulations Grant 7,682,632 - Oshlack , et al. March 23, 2 | 2010-03-23 |
| Controlled Release Oxycodone Compositions App 20100034876 - Oshlack; Benjamin ; et al. | 2010-02-11 |
| Tamper-resistant oral opioid agonist formulations Grant 7,658,939 - Oshlack , et al. February 9, 2 | 2010-02-09 |
| Controlled release hydrocodone formulations App 20090202629 - Oshlack; Benjamin ; et al. | 2009-08-13 |
| Melt-extrusion Multiparticulates App 20090148517 - Oshlack; Benjamin ; et al. | 2009-06-11 |
| Controlled release hydrocodone formulations Grant 7,514,100 - Oshlack , et al. April 7, 2 | 2009-04-07 |
| Melt-extrusion multiparticulates Grant 7,510,727 - Oshlack , et al. March 31, 2 | 2009-03-31 |
| Pharmaceutical Composition Containing Gelling Agent App 20090081287 - Wright; Curtis ; et al. | 2009-03-26 |
| Orally Adminstrable Opioid Formulations Having Extended Duration Of Effect App 20090068269 - Oshlack; Benjamin ; et al. | 2009-03-12 |
| Disposal System For Transdermal Dosage Form App 20080262284 - Marcenyac; Geraldine ; et al. | 2008-10-23 |
| Orally Administrable Opioid Formulations Having Extended Duration Of Effect App 20080181941 - Oshlack; Benjamin ; et al. | 2008-07-31 |
| Controlled release oxycodone compositions App 20080075781 - Oshlack; Benjamin ; et al. | 2008-03-27 |
| Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer App 20080063712 - Oshlack; Benjamin ; et al. | 2008-03-13 |
| Orally Administrable Opioid Formulations Having Extended Duration Of Effect App 20080044482 - Oshlack; Benjamin ; et al. | 2008-02-21 |
| Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer Grant 7,316,821 - Oshlack , et al. January 8, 2 | 2008-01-08 |
| Controlled release oxycodone compositions App 20070275065 - Oshlack; Benjamin ; et al. | 2007-11-29 |
| Controlled release oxycodone compositions App 20070275062 - Oshlack; Benjamin ; et al. | 2007-11-29 |
| Orally administrable opioid formulations having extended duration of effect Grant 7,270,831 - Oshlack , et al. September 18, 2 | 2007-09-18 |
| Tamper resistant dosage form comprising co-extruded, sequestered adverse agent particles and process of making same App 20070065364 - Oshlack; Benjamin ; et al. | 2007-03-22 |
| Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent Grant 7,144,587 - Oshlack , et al. December 5, 2 | 2006-12-05 |
| Pharmaceutical formulation containing bittering agent Grant 7,141,250 - Oshlack , et al. November 28, 2 | 2006-11-28 |
| Pharmaceutical combinations of hydrocodone and naltrexone App 20060194826 - Oshlack; Benjamin ; et al. | 2006-08-31 |
| Sequestered antagonist formulations App 20060182801 - Breder; Christopher ; et al. | 2006-08-17 |
| Controlled release oxycodone compositions App 20060165792 - Oshlack; Benjamin ; et al. | 2006-07-27 |
| Controlled release oxycodone compositions App 20060165791 - Oshlack; Benjamin ; et al. | 2006-07-27 |
| Controlled release formulations coated with aqueous dispersions of acrylic polymers Grant 7,070,806 - Oshlack , et al. July 4, 2 | 2006-07-04 |
| Powder-layered oral dosage forms Grant 7,060,293 - Oshlack , et al. June 13, 2 | 2006-06-13 |
| Controlled release oxycodone compositions App 20060099255 - Oshlack; Benjamin ; et al. | 2006-05-11 |
| Controlled release oxycodone compositions App 20060057210 - Oshlack; Benjamin ; et al. | 2006-03-16 |
| Tamper-resistant oral opioid agonist formulations App 20060039970 - Oshlack; Benjamin ; et al. | 2006-02-23 |
| Pharmaceutical compositions App 20050266072 - Oshlack, Benjamin ; et al. | 2005-12-01 |
| Tamper-resistant oral opioid agonist formulations App 20050181046 - Oshlack, Benjamin ; et al. | 2005-08-18 |
| Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer Grant 6,905,709 - Oshlack , et al. June 14, 2 | 2005-06-14 |
| Tamper-resistant oral opioid agonist formulations App 20050095291 - Oshlack, Benjamin ; et al. | 2005-05-05 |
| Melt-extruded orally administrable opioid formulations App 20050089568 - Oshlack, Benjamin ; et al. | 2005-04-28 |
| Controlled release hydrocodone formulations App 20040266807 - Oshlack, Benjamin ; et al. | 2004-12-30 |
| Abuse resistant opioid containing transdermal systems App 20040241218 - Tavares, Lino ; et al. | 2004-12-02 |
| Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer App 20040228917 - Oshlack, Benjamin ; et al. | 2004-11-18 |
| Pharmaceutical products App 20040228924 - Oshlack, Benjamin ; et al. | 2004-11-18 |
| Tamper-resistant oral opioid agonist formulations App 20040186121 - Oshlack, Benjamin ; et al. | 2004-09-23 |
| Controlled release oxycodone compositions App 20040185098 - Oshlack, Benjamin ; et al. | 2004-09-23 |
| Melt-extrusion multiparticulates App 20040185096 - Oshlack, Benjamin ; et al. | 2004-09-23 |
| Controlled-release compositions containing opioid agonist and antagonist App 20040176402 - Oshlack, Benjamin ; et al. | 2004-09-09 |
| Method and apparatus for compouding individualized dosege forms App 20040172169 - Wright, Curtis IV ; et al. | 2004-09-02 |
| Once-a-day oxycodone formulations App 20040170680 - Oshlack, Benjamin ; et al. | 2004-09-02 |
| Disposal system for transdermal dosage form App 20040146547 - Marcenyac, Geraldine ; et al. | 2004-07-29 |
| Controlled/modified release oral methylphenidate formulations App 20040131680 - Goldenheim, Paul D. ; et al. | 2004-07-08 |
| Orally adminstrable opioid formulations having extended duration of effect App 20040121001 - Oshlack, Benjamin ; et al. | 2004-06-24 |
| Controlled release oxycodone compositions App 20040105887 - Oshlack, Benjamin ; et al. | 2004-06-03 |
| Melt-extruded orally administrable opioid formulations Grant 6,743,442 - Oshlack , et al. June 1, 2 | 2004-06-01 |
| Controlled release oxycodone compositions App 20040096500 - Oshlack, Benjamin ; et al. | 2004-05-20 |
| Tamper-resistant oral opioid agonist formulations App 20040092542 - Oshlack, Benjamin ; et al. | 2004-05-13 |
| Controlled release hydrocodone formulations Grant 6,733,783 - Oshlack , et al. May 11, 2 | 2004-05-11 |
| Melt-extruded orally administrable opioid formulations App 20040081694 - Oshlack, Benjamin ; et al. | 2004-04-29 |
| Controlled-release compositions containing opioid agonist and antagonist Grant 6,716,449 - Oshlack , et al. April 6, 2 | 2004-04-06 |
| Melt-extrusion multiparticulates Grant 6,706,281 - Oshlack , et al. March 16, 2 | 2004-03-16 |
| Controlled release hydrocodone formulations App 20040047907 - Oshlack, Benjamin ; et al. | 2004-03-11 |
| Tamper-resistant oral opioid agonist formulations Grant 6,696,088 - Oshlack , et al. February 24, 2 | 2004-02-24 |
| Controlled/modified release oral methylphenidate formulations Grant 6,673,367 - Goldenheim , et al. January 6, 2 | 2004-01-06 |
| Naltrexone hydrochloride compositions App 20030229111 - Oshlack, Benjamin ; et al. | 2003-12-11 |
| Stabilized sustained release tramadol formulations Grant 6,645,527 - Oshlack , et al. November 11, 2 | 2003-11-11 |
| Controlled release formulations coated with aqueous dispersions of acrylic polymers App 20030198673 - Oshlack, Benjamin ; et al. | 2003-10-23 |
| Sustained-release gel coated compositions App 20030190362 - Sackler, Richard S. ; et al. | 2003-10-09 |
| Sustained release hydromorphone formulations exhibiting bimodal characteristics App 20030190358 - Oshlack, Benjamin ; et al. | 2003-10-09 |
| Orally administrable opioid formulations having extended duration of effect App 20030180361 - Oshlack, Benjamin ; et al. | 2003-09-25 |
| Sequestered antagonist formulations App 20030157168 - Breder, Christopher ; et al. | 2003-08-21 |
| Tamper-resistant oral opioid agonist formulations App 20030143269 - Oshlack, Benjamin ; et al. | 2003-07-31 |
| Sustained release oxycodone formulations with no fed/fast effect App 20030129231 - Oshlack, Benjamin ; et al. | 2003-07-10 |
| Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent App 20030124185 - Oshlack, Benjamin ; et al. | 2003-07-03 |
| Orally administrable opioid formulations having extended duration of effect Grant 6,572,885 - Oshlack , et al. June 3, 2 | 2003-06-03 |
| Controlled release oxycodone compositions App 20030099704 - Oshlack, Benjamin ; et al. | 2003-05-29 |
| Opioid agonist formulations with releasable and sequestered antagonist App 20030073714 - Breder, Christopher ; et al. | 2003-04-17 |
| Pharmaceutical formulation containing opioid agonist,opioid antagonist and gelling agent App 20030068371 - Oshlack, Benjamin ; et al. | 2003-04-10 |
| Pharmaceutical formulation containing gelling agent App 20030068375 - Wright, Curtis ; et al. | 2003-04-10 |
| Pharmaceutical combinations of oxycodone and naloxone App 20030069263 - Breder, Christopher D. ; et al. | 2003-04-10 |
| Pharmaceutical formulation containing bittering agent App 20030064099 - Oshlack, Benjamin ; et al. | 2003-04-03 |
| Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer App 20030054032 - Oshlack, Benjamin ; et al. | 2003-03-20 |
| Melt-extrusion multiparticulates App 20030026839 - Oshlack, Benjamin ; et al. | 2003-02-06 |
| Immediate release tablet cores of insoluble drugs having sustained-release coating Grant 6,387,404 - Oshlack , et al. May 14, 2 | 2002-05-14 |
| Melt-extrusion multiparticulates Grant 6,335,033 - Oshlack , et al. January 1, 2 | 2002-01-01 |
| Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer Grant 6,316,031 - Oshlack , et al. November 13, 2 | 2001-11-13 |
| Stabilized sustained release tramadol formulations Grant 6,306,438 - Oshlack , et al. October 23, 2 | 2001-10-23 |
| Orally administrable opioid formulations having extended duration of effect Grant 6,294,195 - Oshlack , et al. September 25, 2 | 2001-09-25 |
| Melt-extruded orally administrable opioid formulations Grant 6,261,599 - Oshlack , et al. July 17, 2 | 2001-07-17 |
| Immediate release tablet cores of acetaminophen having sustained-release coating Grant 6,210,714 - Oshlack , et al. April 3, 2 | 2001-04-03 |
| Controlled release formulations coated with aqueous dispersions of acrylic polymers Grant 6,143,353 - Oshlack , et al. November 7, 2 | 2000-11-07 |
| Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer Grant 6,129,933 - Oshlack , et al. October 10, 2 | 2000-10-10 |
| Opioid formulations having extended controlled release Grant 6,103,261 - Chasin , et al. August 15, 2 | 2000-08-15 |
| Powder-layered oral dosage forms Grant 6,077,533 - Oshlack , et al. June 20, 2 | 2000-06-20 |
| Immediate release tablet cores of insoluble drugs having sustained-release coating Grant 6,024,982 - Oshlack , et al. February 15, 2 | 2000-02-15 |
| Orally administrable opioid formulations having extended duration of effect Grant 5,968,551 - Oshlack , et al. October 19, 1 | 1999-10-19 |
| Extruded multi-particulates Grant 5,965,161 - Oshlack , et al. October 12, 1 | 1999-10-12 |
| Extruded orally administrable opioid formulations Grant 5,958,452 - Oshlack , et al. September 28, 1 | 1999-09-28 |
| Opioid formulations having extended controlled released Grant 5,958,459 - Chasin , et al. September 28, 1 | 1999-09-28 |
| Emollient antimicrobial formulations containing povidone iodine Grant 5,716,611 - Oshlack , et al. February 10, 1 | 1998-02-10 |
| Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer Grant 5,681,585 - Oshlack , et al. October 28, 1 | 1997-10-28 |
| Controlled release oxycodone compositions Grant 5,656,295 - Oshlack , et al. August 12, 1 | 1997-08-12 |
| Controlled release formulations coated with aqueous dispersions of acrylic polymers Grant 5,639,476 - Oshlack , et al. June 17, 1 | 1997-06-17 |
| Controlled release formulations coated with aqueous dispersions of acrylic polymers Grant 5,580,578 - Oshlack , et al. December 3, 1 | 1996-12-03 |
| Controlled release oxycodone compositions Grant 5,549,912 - Oshlack , et al. August 27, 1 | 1996-08-27 |
| Controlled release oxycodone compositions Grant 5,508,042 - Oshlack , et al. April 16, 1 | 1996-04-16 |
| Immediate release tablet cores of insoluble drugs having sustained-release coating Grant 5,500,227 - Oshlack , et al. March 19, 1 | 1996-03-19 |
| Controlled-release formulations coated with aqueous dispersions of ethylcellulose Grant 5,472,712 - Oshlack , et al. * December 5, 1 | 1995-12-05 |
| Powder-layered morphine sulfate formulations Grant 5,411,745 - Oshlack , et al. May 2, 1 | 1995-05-02 |
| Controlled release coatings derived from aqueous dispersions of zein Grant 5,356,467 - Oshlack , et al. October 18, 1 | 1994-10-18 |
| Aqueous dispersions of zein and preparation thereof Grant 5,324,351 - Oshlack , et al. June 28, 1 | 1994-06-28 |
| Stabilized controlled release formulations having acrylic polymer coating Grant 5,286,493 - Oshlack , et al. February 15, 1 | 1994-02-15 |
| Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer Grant 5,273,760 - Oshlack , et al. December 28, 1 | 1993-12-28 |
| Controlled release oxycodone compositions Grant 5,266,331 - Oshlack , et al. * November 30, 1 | 1993-11-30 |
| Stabilized PVP-I solutions Grant 5,126,127 - Bhagwat , et al. June 30, 1 | 1992-06-30 |
| Controlled release bases for pharmaceuticals Grant 4,970,075 - Oshlack * November 13, 1 | 1990-11-13 |
| Controlled release bases for pharmaceuticals Grant 4,861,598 - Oshlack August 29, 1 | 1989-08-29 |
| Tablet Grant D301,762 - Oshlack June 20, 1 | 1989-06-20 |
| Extended action controlled release compositions Grant 4,443,428 - Oshlack , et al. April 17, 1 | 1984-04-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 